Quantcast
Home / Practice Areas / Business and Civil Practice / Rulings give lawyers roadmap for suing drug makers for marketing fraud

Rulings give lawyers roadmap for suing drug makers for marketing fraud

In the first ruling of its kind, a federal appeals court upheld a $142 million jury verdict against drug maker Pfizer for fraudulent marketing based on statistical evidence that its marketing campaign caused doctors to prescribe epilepsy drug Neurontin for unapproved uses.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top